FMO9 Activators
FMO9 Activators are a distinctive class of chemical compounds that, through their interaction with cellular biochemical pathways, have the potential to indirectly enhance the activity of the flavin-containing monooxygenase 9 (FMO9) enzyme. This enzyme is part of the FMO family, which plays a crucial role in the metabolism of a diverse array of xenobiotics, including drugs, pesticides, and other environmental compounds. Rather than directly binding to or modifying the active site of FMO9, these activators exert their effects by modulating the cellular environment or the expression of the enzyme itself. They achieve this by upregulating cellular pathways that are responsible for the maintenance of redox balance and the elimination of toxic substances. For example, many FMO9 Activators are known to stimulate the Nuclear Factor Erythroid 2–Related Factor 2 (NRF2) pathway, a master regulator of the antioxidant response and detoxification processes. Activation of this pathway can lead to an increased synthesis of various detoxification and antioxidant proteins, which may include FMO9, thereby potentially enhancing its functional activity and stability within the cell.
The array of compounds that fall under the umbrella of FMO9 Activators is diverse, encompassing molecules from different chemical families with varied structures and properties. These activators typically possess functional groups or molecular frameworks that are capable of engaging with cellular signaling pathways. Some of these compounds are naturally occurring in the diet, such as certain phytochemicals found in fruits and vegetables, while others might be synthetic molecules designed to engage with specific biochemical pathways. Despite the chemical heterogeneity, the common thread among FMO9 Activators is their capacity to foster an intracellular milieu that supports the optimal activity of FMO9. This is achieved by either enhancing the enzyme's expression or by influencing factors that contribute to its stability and proper functioning, such as the cellular redox state.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates the NRF2 pathway, which regulates the expression of antioxidant proteins that protect against oxidative damage. By initiating this pathway, FMO9 activity could be enhanced due to the protective environment against oxidative stress, which may improve FMO9's stability and function in metabolism. | ||||||
Indole-3-carbinol | 700-06-1 | sc-202662 sc-202662A sc-202662B sc-202662C sc-202662D | 1 g 5 g 100 g 250 g 1 kg | $39.00 $61.00 $146.00 $312.00 $1032.00 | 5 | |
Indole-3-carbinol stimulates the production of cytochrome P450 enzymes, which work in concert with FMO9 in xenobiotic metabolism. This compound could indirectly increase FMO9 activity by promoting the metabolic processes that involve FMO9, thus aiding in the clearance of metabolic substrates. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Oltipraz induces the NRF2-dependent antioxidant response, which could indirectly increase FMO9 activity. This enhancement is due to the improved cellular defense mechanisms where FMO9 operates, potentially maximizing its role in detoxification pathways. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin upregulates the expression of phase II detoxification enzymes, potentially including FMO9, by acting on the NRF2 pathway. This action could enhance FMO9's role in detoxification, as it may facilitate the clearance of compounds that FMO9 helps metabolize. | ||||||
3,3′-Diindolylmethane | 1968-05-4 | sc-204624 sc-204624A sc-204624B sc-204624C sc-204624D sc-204624E | 100 mg 500 mg 5 g 10 g 50 g 1 g | $37.00 $65.00 $89.00 $421.00 $681.00 $66.00 | 8 | |
DIM influences both phase I and phase II detoxification enzymes, which could enhance FMO9 activity by optimizing the enzyme balance for metabolic processes that FMO9 is part of, improving the detoxification capacity of the cell. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $40.00 | 7 | |
Andrographolide activates NRF2, potentially enhancing FMO9 activity by bolstering the cellular antioxidant systems that support FMO9's metabolic functions. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can enhance the expression of phase II detoxification enzymes via NRF2 activation, which could lead to an indirect increase in FMO9 activity by intensifying the detoxification processes that rely on FMO9. | ||||||
Cinnamic Aldehyde | 104-55-2 | sc-294033 sc-294033A | 100 g 500 g | $104.00 $228.00 | ||
Cinnamaldehyde's ability to induce phase I and phase II detoxification enzymes could enhance the activity of FMO9 by amplifying the metabolic pathways that process xenobiotics, many of which may involve FMO9. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate, by activating NRF2, could enhance FMO9 activity by promoting the expression of phase II detoxifying enzymes, thereby strengthening the detoxification mechanisms where FMO9 functions. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol's activation of sirtuins and induction of phase II enzyme expression could enhance FMO9 activity by increasing the metabolic processes that involve FMO9, thus aiding in the metabolic handling of various compounds. | ||||||